Prestige Consumer Healthcare Inc. (PBH) vs Supernus Pharmaceuticals, Inc. (SUPN)
- Prestige Consumer Healthcare Inc. PBH 49.92 +1.46%
- Supernus Pharmaceuticals, Inc. SUPN 37.88 −4.27%
Prestige Consumer Healthcare Inc. and Supernus Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Prestige Consumer Healthcare Inc. and Supernus Pharmaceuticals, Inc. are of similar size ($2.3B and $2.3B). Supernus Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Prestige Consumer Healthcare Inc. trades at 13.9×. Supernus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 24.9% against −1.36%. Prestige Consumer Healthcare Inc. has the higher net margin (15.6% vs −13.2%) and the higher return on invested capital (4.70% vs −12.4%). Across the 20 metrics below, Prestige Consumer Healthcare Inc. leads on 14 and Supernus Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | PBH | SUPN | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 53.53% | 88.07% | 53.94% |
| Operating margin | 26.26% | (15.71%) | 0.00% |
| Net margin | 15.57% | (13.23%) | 0.00% |
| Free cash flow margin | 21.30% | 2.21% | 0.00% |
| Return on equity | 9.12% | (10.49%) | (0.40%) |
| Return on assets | 4.30% | (7.82%) | (3.32%) |
| Return on invested capital | 4.70% | (12.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack